Sigma Pharmaceuticals Ltd (SIG)

Currency in AUD
2.860
0.000(0.00%)
Closed·
SIG Scorecard
Full Analysis
Net income is expected to grow this year
SIG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8502.920
52 wk Range
1.2153.320
Key Statistics
Bid/Ask
2.85 / 2.86
Prev. Close
2.86
Open
2.86
Day's Range
2.85-2.92
52 wk Range
1.215-3.32
Volume
9.96M
Average Volume (3m)
35.6M
1-Year Change
132.52%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SIG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.700
Downside
-5.59%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Sigma Pharmaceuticals Ltd Company Profile

As of February 4, 2025, Sigma Healthcare Limited was acquired by CW Group Holdings Limited, in a reverse merger transaction. Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners. The company was founded in 1912 and is headquartered in Clayton, Australia.

Compare SIG to Peers and Sector

Metrics to compare
SIG
Peers
Sector
Relationship
P/E Ratio
-4.4x−0.5x
PEG Ratio
-0.010.00
Price/Book
-1.6x2.6x
Price / LTM Sales
-1.9x3.3x
Upside (Analyst Target)
3.8%38.5%43.5%
Fair Value Upside
Unlock−0.2%6.8%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2.700
(-5.59% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.01%
Dividend Yield
0.36%
Industry Median 1.76%
Annualised payout
0.01
Paid unevenly
5-Years Growth
-12.94%
Growth Streak

Earnings

Latest Release
Mar 20, 2025
EPS / Forecast
-0.01 / 1.46
Revenue / Forecast
3.00B / 2.327B
EPS Revisions
Last 90 days

SIG Income Statement

People Also Watch

308.50
PME
-3.55%
41.26
CPU
+1.40%
21.390
QBE
-8.78%
43.020
RMD
0.00%
4.970
TLS
-0.40%

FAQ

What Stock Exchange Does Sigma Pharma Trade On?

Sigma Pharma is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Sigma Pharma?

The stock symbol for Sigma Pharma is "SIG."

What Is the Sigma Pharma Market Cap?

As of today, Sigma Pharma market cap is 4.50B.

What Is Sigma Pharma's Earnings Per Share (TTM)?

The Sigma Pharma EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is SIG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Sigma Pharma Stock Split?

Sigma Pharma has split 2 times.

How Many Employees Does Sigma Pharma Have?

Sigma Pharma has 0 employees.

What is the current trading status of Sigma Pharma (SIG)?

As of 09 Aug 2025, Sigma Pharma (SIG) is trading at a price of 2.86, with a previous close of 2.86. The stock has fluctuated within a day range of 2.85 to 2.92, while its 52-week range spans from 1.22 to 3.32.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.